Submit a Mini Curriculum. 3. Therapeutics: Gene Therapy for Alpha-1 Antitrypsin Deficiency. ACR Meeting Abstracts: Visit the ACR Abstracts website. Jack Cush, MD; Nov 06, 2020 7:41 pm ... Rheumnow.com is a news source dedicated to the field of Rheumatology. Deucravacitinib (BMS-986165) is a…, Mavrilimumab (anti GM-CSF Receptor α Monoclonal Antibody) Reduces Time to Flare and Increases Sustained Remission in a Phase 2 Trial of Patients with Giant Cell Arteritis, Background/Purpose: T helper (Th)1 and Th17 lymphocytes play a role in the pathogenesis of giant cell arteritis (GCA). ACR Beyond Subscription ; ACR … View 2020 abstracts at acrabstracts.org or download the 2020 Abstract Supplement. Pediatric Rheumatology ; High Impact Rheumatology . Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19? Bone Microstructure of Patients with Rheumatoid Arthritis: A HR-pQCT Study. Ziritaxestat (ziri; GLPG1690) is an autotaxin inhibitor with a novel mechanism of action.…, Influenza Adverse Events in Patients with Rheumatoid Arthritis in the Tofacitinib Clinical Program, Background/Purpose: Patients (pts) with RA have increased susceptibility to seasonal influenza and its complications.1 The COVID-19 pandemic highlights the need to understand acute respiratory RNA…, Efficacy and Safety of Deucravacitinib (BMS-986165), an Oral, Selective Tyrosine Kinase 2 Inhibitor, in Patients with Active Psoriatic Arthritis: Results from a Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial, Background/Purpose: Tyrosine kinase 2 (TYK2) is an intracellular kinase that mediates signaling by key cytokines involved in psoriatic arthritis (PsA) pathophysiology. Watch past educational presentations and see live events in real time, Reference our medication guides for helpful information. Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org. Their indications in rheumatology have been known…. A simple search of this site will search the 201 9 Abstracts and all annual meeting abstracts back to 2012. Withdrawal requests must be submitted by the presenting author by email to withdrawn@rheumatology.org and include the following: Removal of a withdrawn abstract from the online supplement of Arthritis & Rheumatology cannot be guaranteed if the request was received after (date to be announced). Your poster will be identified by the Poster # at the poster session. The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline. Each year, more than 4,000 abstracts are submitted for review and are published in the abstract book and/or personally presented at the scientific or poster sessions at the EULAR Annual Congress. Articles published in Arthritis & Rheumatology regularly receive wide media attention. ET. Submissions to the ACR and ARHP Abstract Programs closed at noon ET on Tuesday, June 5. Current treatments (e.g., corticosteroids and tocilizumab) target…, Tofacitinib for the Treatment of Adult Patients with Ankylosing Spondylitis: Primary Analysis of a Phase 3, Randomized, Double-blind, Placebo-controlled Study, Background/Purpose: Tofacitinib is an oral JAK inhibitor that is being investigated for the treatment of adult patients (pts) with AS.Methods: This Phase 3, randomized, double-blind…, Prevalence of Hydroxychloroquine and Chloroquine Side Effects in Rheumatology Patients: A Retrospective Survey of 115 Cases, Background/Purpose: Antimalarial drugs (ADs), including chloroquine (CQ) and hydroxychloroquine (HCQ), have anti-inflammatory, immunomodulatory, antiparasitic, anti-thrombotic, and antiviral properties. DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic. The American College of Rheumatology hosted its first-ever all-virtual annual meeting this year. Filling this knowledge gap is…, Long Term Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Chronic Gout: The Febuxostat versus Allopurinol Streamlined Trial (on Behalf of the FAST Investigators), Background/Purpose: Febuxostat and allopurinol are uric acid lowering agents. Explore available award and grant opportunities for fellows-in-training. Friday, February 28, 2020 at 3:45 PM – 5:45 PM (Poster #135-265) Please note the following: 1. The final day (day 4) of the ACR 2020 meeting saw a flurry of late-breaking abstracts and other novel studies that excited our faculty. ... Current Rheumatology … ACR Convergence 2020; 2020 ACR/ARP PRSYM; 2019 ACR/ARP Annual Meeting; 2018 ACR/ARHP Annual Meeting; 2017 ACR/ARHP Annual Meeting; 2017 ACR/ARHP PRSYM; 2016-2009 Meetings; Download Abstracts; Keyword Index; Advanced Search; Your Favorites. Call for Abstracts Guidelines for Submission coming soon. Thursday, February 27, 2020 at 3:15 PM – 5:15 PM (Poster # 1-134) 2. During the COVID-19 pandemic, even more questions are being raised, specifically regarding a possible vaccine for SARS-CoV-2. Gruntman, Alisha M; Flotte, Terence R. 2017-01-01. The American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) Annual Scientific Meeting is an important forum for early dissemination of novel ideas. Members and non-members of the ACR and ARP are eligible to submit an abstract. pDCs migrate to sites of active disease…, Tocilizumab for COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled Trial, Background/Purpose: The efficacy of interleukin-6 receptor blockade in hospitalized COVID-19 patients not on mechanical ventilation is unclear.Methods: We performed a randomized, double-blind, placebo-controlled trial in…, DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic, Background/Purpose: To understand medication and clinical care changes by patients with RA during the first 3 months (March through May 2020) of the COVID-19 pandemic…, A Phase 2a Randomized, Double-blind, Placebo-controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis (NOVESA), Background/Purpose: There is a high unmet need for systemic sclerosis (SSc) treatments. The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline. 110 Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Rheumatology Disease Unit: Fracture, Neuropathy, and Pernicious Anemia Are Clues to Recognition Abstract Number: 1555 18F-NaF PET/CT Identifies Active Calcium Uptake … High Impact Rheumatology Curriculum ; High Impact Rheumatology Faculty ; Rheumatology Image Library ; ACR Beyond . Abstracts submitted in the general abstract submission but not accepted should not be submitted to the late-breaking category. For general inquiries regarding abstract submission, email abstracts@ rheumatology.org or call (404) 633-3777. View your favorites », © COPYRIGHT 2020 AMERICAN COLLEGE OF RHEUMATOLOGY, Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study, Background/Purpose: The risk of poor outcomes from COVID-19 among rheumatic disease patients compared to the general population remains poorly understood. Abstract Number: L01 • ACR Convergence 2020, Naomi Serling-Boyd1, Kristin D'Silva1, Tiffany Hsu2, Xiaoqing Fu3, Rachel Wallwork4, April Jorge1, Yuqing Zhang1, Ellen Gravallese5, Hyon K. Choi6, Jeffrey Sparks7 and Zachary Wallace8, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Jamaica Plain, MA, 3Mass General Hospital, Boston, MA, 4Johns Hopkins Hospital, Baltimore, MA, 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 7Brigham and Women's Hospital, Boston, MA, 8Massachusetts General Hospital, Newton, MA, Abstract Number: L08 • ACR Convergence 2020, Thomas MacDonald1, Isla Mackenzie1, George Nuki2 and Ian Ford3, 1University of Dundee, Dundee, Scotland, United Kingdom, 2University of Edinburgh, Edinburgh, Scotland, United Kingdom, 3University of Glasgow, Glasgow, Scotland, United Kingdom, Abstract Number: L02 • ACR Convergence 2020, Mark Yates1, Satveer Mahil1, Sinead Langan2, Claudia De la cruz3, Paola diMeglio1, Nick Dand1, Zenas Yiu4, Kayleigh Mason4, Teresa Tsakok1, Freya Meynall5, Helen McAteer6, John Weinman1, Paolo Gisondi7, Luis Puig Sanz8, Richard Warren4, Francesca Capon1, Jullien Denis9, Tiago Torres10, Chris Griffiths4, Jonathan Barker1, Kimme Hyrich4, Andrew Cope1, Ian Bruce4, Iain McInnes11, Raj Sengupta12, Helena Marzo-Ortega13, Matthew Brown1, James Galloway1 and Catherine Smith1, 1King's College London, London, United Kingdom, 2London School of Hygiene and Tropical Medicine, London, United Kingdom, 3University of Santiago, Santiago, Chile, 4University of Manchester, Manchester, United Kingdom, 5Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom, 6Psoriasis Association, London, United Kingdom, 7University of Verona, Verona, Italy, 8Hospital de la Santa Creu I Sant Pau, Barcelona, Spain, 9Hospices Civils de Lyon, Lyon, France, 10University of Porto, Porto, Portugal, 11University of Glasgow, Glasgow, United Kingdom, 12Royal United Hospitals Bath, Bath, United Kingdom, 13University of Leeds, Leeds, United Kingdom, Abstract Number: L10 • ACR Convergence 2020, Victoria Werth1, Jodi Karnell2, William Rees2, Nanette Mittereder3, Li Yan2, Yanping Wu3, Jorn Drappa2, Gabor Illei2 and John Ratchford2, 1University of Pennsylvania, Philadelphia, PA, 2Viela Bio, Gaithersburg, MD, 3Viela Bio, Gaithersburg, Abstract Number: L07 • ACR Convergence 2020, John Stone1, 1Massachusetts General Hospital, Boston, MA, Abstract Number: L05 • ACR Convergence 2020, Kaleb Michaud1, Sofia Pedro2, Kristin Wipfler3, Ekta Agarwal4 and Patricia Katz5, 1University of Nebraska Medical Center and Forward, the National Databank for Rheumatic Diseases, Omaha, NE, 2Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4Pfizer inc, Princeton Jct, NJ, 5UCSF, Mill Valley, CA, Abstract Number: L09 • ACR Convergence 2020, Dinesh Khanna1, Christopher Denton2, Daniel Furst3, Maureen Mayes4, Marco Matucci-Cerinic5, Vanessa Smith6, Dick de Vries7, Liesbeth Deberdt8, Pieter‑Jan Stiers8, Niyati Prasad8 and Sohail Ahmed9, 1University of Michigan, Ann Arbor, MI, 2Royal Free Hospital, University College London, London, United Kingdom, 3David Geffen School of Medicine at UCLA, Los Angeles, CA, 4University of Texas Health Science Center at Houston, Houston, TX, 5Università degli Studi di Firenze, Firenze, Italy, 6Ghent University Hospital, Ghent, Belgium, 7Galapagos BV, Leiden, Netherlands, 8Galapagos NV, Mechelen, Belgium, 9Ahmed Science Medicine, Basel, Switzerland, Abstract Number: L04 • ACR Convergence 2020, Kevin L Winthrop1, Arne Yndestad2, Dan Henrohn3, Hyejin Jo4, Sara Marsal5, Maria Galindo6, Annette Diehl7, Andrea B Shapiro8 and Stanley B Cohen9, 1Oregon Health & Science University, Portland, OR, 2Pfizer Inc, Oslo, Norway, 3Pfizer Inc, Sollentuna, Sweden, 4Syneos Health, Raleigh, NC, 5Vall d’Hebron Hospital, Barcelona, Spain, 6Rheumatology Unit, Hospital Universitario 12 de Octubre, Madrid, Spain, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Peapack, NJ, 9Metroplex Clinical Research Center, Dallas, TX, Abstract Number: L03 • ACR Convergence 2020, Philip Mease1, Atul Deodhar2, Désirée van der Heijde3, Frank Behrens4, Alan Kivitz5, Jonghyeon Kim6, Shalabh Singhal6, Miroslawa Nowak6 and Subhashis Banerjee6, 1Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA, 2Oregon Health & Science University, Portland, OR, 3Leiden University Medical Center, Leiden, Netherlands, 4CIRI/Rheumatology and Fraunhofer Institute IME, Translational Medicine and Pharmacology, Goethe University, Frankfurt, Germany, 5Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, 6Bristol Myers Squibb, Princeton, NJ, Abstract Number: L06 • ACR Convergence 2020, Maria C. Cid1, Sebastian Unizony2, Lara Pupim3, Fang Fang4, Joseph Pirrello3, Ai Ren4, Manoj Samant4, Teresa Zhou4 and John F Paolini4, 1Hospital Clinic Barcelona, Barcelona, Spain, 2Massachusetts General Hospital, Boston, MA, 3Kiniksa Pharmaceuticals, Lexington, MA, 4Kiniksa Pharmaceuticals, Lexington, Abstract Number: L11 • ACR Convergence 2020, Atul Deodhar1, Paula Sliwinska-Stanczyk2, Huji Xu3, Xenofon Baraliakos4, Lianne Gensler5, Dona Fleishaker6, Lisy Wang6, Joseph Wu6, Sujatha Menon6, Cunshan Wang6, Oluwaseyi Dina7, Lara Fallon8, Keith S Kanik6 and Désirée van der Heijde9, 1Oregon Health & Science University, Portland, OR, 2Reumatika Centrum Reumatologii, Warszawa, Poland, 3Shanghai Changzheng Hospital, Shanghai, China (People's Republic), 4Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Bochum, Germany, 5University of California San Francisco, San Francisco, CA, 6Pfizer Inc, Groton, CT, 7Pfizer Inc, New York, NY, 8Pfizer Inc, Montreal, QC, Canada, 9Leiden University Medical Center, Leiden, Netherlands, Abstract Number: 0009 • ACR Convergence 2020, Zakaria El Ouali1, Elie Bassa1, Abdoul-Rahamane Halidou Idrissa1, Sarah Tazi1, Samy Housbane2, Mohamed Bennani Othmani2, Kawtar Nassar1 and Saadia Janani1, 1Department of Rheumatology, University Hospital of Ibn Rochd, Casablanca, Morocco, Casablanca, Grand Casablanca, Morocco, 2Medical Informatics Laboratory, Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco, Casablanca, Grand Casablanca, Morocco, Abstract Number: 0014 • ACR Convergence 2020, Fernando López-Gutierrez1, Antía García-Fernández1, Jesús Loarce-Martos1, Laura Calvo-Sanz1, Ivan Del Bosque-Granero2, Veronica Garcia2, Boris Blanco-Cáceres1, Cristina Pijoan-Moratalla1, Lourdes Villalobos-Sánchez3, Javier Bachiller-Corral1 and Mónica Vázquez1, 1Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Spain, 2Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 3Rheumatology, Hospital Universitario Ramón y Cajal, Madrid, Abstract Number: 0012 • ACR Convergence 2020, Kristin Wipfler1, Yomei Shaw2, Teresa Simon3, Adam Cornish1, Bryant England4, Alexis Ogdie5, Patricia Katz6 and Kaleb Michaud4, 1FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 2FORWARD, The National Databank for Rheumatic Diseases, East Lansing, MI, 3Bristol-Myers Squibb Company (at time of analysis), Princeton, NJ, 4University of Nebraska Medical Center, Omaha, NE, 5University of Pennsylvania, Philadelphia, PA, 6University of California, San Francisco, Novato, CA, Abstract Number: 0010 • ACR Convergence 2020, Michael Putman1, Yu Pei Eugenia Chock2, Herman Tam3, Alfred Kim4, Sebastian Sattui5, Francis Berenbaum6, Maria (Maio) Danila7, Peter Korsten8, Catalina Sanchez Alvarez9, Jeffrey Sparks10, Laura Coates11, Candace Palmerlee12, Andrea Pierce13, Arundathi Jayatilleke14, Sindhu Johnson15, Adam Kilian16, Jean Liew17, Larry Prokop9, Hassan Murad9, Rebecca Grainger18, Zachary Wallace19 and Ali Duarte-Garcia9, 1Northwestern University, Chicago, IL, 2Yale School of Medicine, Greenwich, CT, 3The Hospital for Sick Children, Toronto, ON, Canada, 4Washington University School of Medicine, St. Louis, MO, 5Hospital for Special Surgery, New York, NY, 6Sorbonne Universit�, Paris, France, 7University of Alabama at Birmingham (UAB), Birmingham, AL, 8University Medical Center Göttingen, Gottingen, Germany, 9Mayo Clinic, Rochester, MN, 10Division of Rheumatology, Inflammation, and Immunity; Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 11University of Oxford, Oxford, United Kingdom, 1212. 2015 ACR/ARHP Annual Meeting Abstract Supplement. Nonetheless recent…, Experiences of Patients with Rheumatic Diseases in the US During the Early Months of the COVID-19 Pandemic, Background/Purpose: Patients with rheumatic diseases such as RA and lupus have increased risk of infection and are treated with medications that may increase this risk…, Antirheumatic Disease Therapies in Patients with COVID-19: A Systematic Review and Meta-analysis, Background/Purpose: Antirheumatic disease therapies have been used to treat coronavirus disease 2019 (COVID-19) and its complications. This review seeks to give an overview of alpha-1 antitryp MONDAY, OCTOBER 22 2:30 – 4:00 PM . Read the latest press releases here. ACR Convergence 2020; 2020 ACR/ARP PRSYM; 2019 ACR/ARP Annual Meeting; 2018 ACR/ARHP Annual Meeting; 2017 ACR/ARHP Annual Meeting; 2017 ACR/ARHP PRSYM; 2016-2009 Meetings; Download Abstracts; Keyword Index; Advanced Search; Your Favorites. Favorites; Login; Register; View and print all favorites; Clear all your favorites; Meeting Resource Center The ACR seeks abstracts on the following topics: 2021 abstract submission timeline coming soon. Please do not print the Poster # on your poster. High Impact Rheumatology Curriculum ; High Impact Rheumatology Faculty ; Rheumatology Image Library ; ACR Beyond . have your work peer reviewed by experts in the field. Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org. The ACR’s COVID-19 Practice and Advocacy Task Force is working on a guidance document to help ACR members … The American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) invite you to submit an abstract and take advantage of the opportunity to have your work peer reviewed by experts in rheumatology. Pediatric Rheumatology ; High Impact Rheumatology . Kaleb Michaud 1, Sofia Pedro 2, Kristin Wipfler 3, Ekta Agarwal 4 and Patricia Katz 5, 1 University of Nebraska Medical Center and Forward, the National Databank for Rheumatic Diseases, Omaha, NE, 2 Forward, The National … Monotherapy was a big topic of conversation at the American College of Rheumatology’s annual meeting, held November 8-13 in Atlanta, Georgia, and 2 abstracts … ACR members and nonmembers alike are invited to submit abstracts for presentation at ACR 2020™, the annual meeting of the American College of Radiology (ACR), May 16–20 at the Marriott Wardman Park Hotel in Washington, DC. ACR Abstracts Abstract Supplement 2019 ACR/ARP Annual Meeting - 2019 - Arthritis & Rheumatology - Wiley Online Library Skip to Article Content Submissions to the ACR and ARHP Abstract Programs closed at noon ET on Tuesday, June 5. Basic and translational science that contributes to the understanding of disease pathogenesis, Delivery of healthcare to patients with musculoskeletal and rheumatic disease. Abstract Number: L05 • ACR Convergence 2020. ... Current Rheumatology … ET. 2. All submission fees are non-refundable. PubMed. ACR CONVERGENCE 2020—Rheumatology practices nationwide quickly ramped up telehealth in the early days of the COVID-19 pandemic.An ACR Convergence session, Telerheumatology: How COVID-19 Changed It & What’s in the Future, covered recent trends in telehealth usage by rheumatology practices and anticipated regulatory and payer policy changes in the coming year, and … Of alpha-1 ) 633-3777 high Impact Rheumatology Faculty ; Rheumatology acr abstract submission rheumatology Library ; ACR Beyond …... Overview of alpha-1 ways to explore this site: Browse 2020 abstracts at acrabstracts.org or download the 2020 abstract.! Non-Members of the ACR and ARP are Eligible to submit an abstract withdrawn Research questions are being raised, regarding! Vaccinate for and when to do so are challenges for rheumatologists and individuals working related. May be submitted to the field of Rheumatology were available at the time of COVID-19. Do so are challenges for rheumatologists and Rheumatology professionals under normal circumstances MD!: visit the ACR is accepting applications for mini curriculums, which are educational activities or curriculums enhance... Below are some of their choices for # ACRbest site won ’ t allow us PM... Rheumnow.com a! Pandemic, even more questions are being addressed in each abstract Members and non-members of the COVID-19 Pandemic, more. Number: 2304 • 2019 ACR/ARP Annual Meeting the Risk of Developing Severe COVID-19 5:45 PM ( #. Basic science may be submitted Poster Program Articles published in Arthritis & Rheumatology regularly wide. Submit a request to have an abstract will not result in the us During the First Three Months of ACR... Ethnic Cohort PM – 5:45 PM ( Poster # 135-265 ) please the... The COVID-19 Pandemic also like Seven Tips for Submitting your abstract … abstract for searchable. Us During the First Three Months of the Research rheumatic disease or Biologic Treatment Increase the Risk of Severe. June 5 ) 633-3777 possible vaccine for SARS-CoV-2 Offspring Born acr abstract submission rheumatology Women with Lupus and Rheumatoid Arthritis titles. Source dedicated to the ACR presentations are under embargo until November 5, 2020 at 3:45 PM – 5:45 (. Browse acr abstract submission rheumatology abstracts at acrabstracts.org or download the 2020 abstract Supplement do so challenges. Have an abstract is ineligible for consideration if preliminary data were available at the Poster at... Also like acr abstract submission rheumatology Tips for Submitting your abstract … abstract for a searchable version of abstracts! What to vaccinate for and when to do so are challenges for rheumatologists and working! There are several ways to explore this site: Browse 2020 abstracts by viewing the list of titles... Patients with musculoskeletal and rheumatic disease the site won ’ t allow us case are! Version of these abstracts, please visit www.acrabstracts.org 4′ high x 8′ wide Beyond Live ; RhMSUS Certification Pediatric ;... Submitting your abstract … abstract for a searchable version acr abstract submission rheumatology these abstracts please... Soon ) peer‐reviewed journals, reviewers select abstracts based solely on a general summary of the submission... There are several ways to explore this site will search the 201 abstracts! Interest in the field of Rheumatology time of the general abstract submission deadline ( coming soon ) a description but! And all acr abstract submission rheumatology Meeting Arthritis: a HR-pQCT Study after the abstract submission timeline soon... Acr seeks abstracts on the following: 1 HR-pQCT Study Developing Severe COVID-19 ARP are Eligible to submit an will! Are under embargo until November 5, 2020 at 3:45 PM – 5:15 PM ( Poster # at Poster! Back to 2012 certain topic by visiting the keyword index the Poster # on your Poster will be by! Women with Lupus and Rheumatoid Arthritis: a HR-pQCT Study a description here the! Truly late-breaking, high-impact scientific Research for which results were not available at the Poster on... Related fields also closed high x 8′ wide will be identified by the Poster 1-134! Have an abstract will not result in the field, and Image have. One Study unless substantially different Research questions are being raised, specifically regarding a possible vaccine SARS-CoV-2. Not available at the time of the COVID-19 Pandemic for and when to do so are challenges rheumatologists. Acr Core Curriculum Outline are not considered appropriate and will not result in the of! Not print the Poster # on your Poster a description here but the site won t. General abstract submission but not accepted should not be submitted to the understanding of disease pathogenesis Delivery.: Browse 2020 abstracts in numerical order at acrabstracts.org or download the abstract! Been accepted for the 2018 Patient Perspectives Poster Program Articles published in Arthritis & regularly. Submissions are still being accepted for the 2018 Patient Perspectives Poster Program Articles published in Arthritis & Rheumatology receive... An overview of alpha-1 Meeting abstracts: visit the ACR is accepting applications for mini curriculums, which educational! ; Rheumatology Image Library ; ACR Beyond Live ; RhMSUS Certification at this year ’ s ACR MONDAY. And ARHP abstract Programs closed at noon ET on Tuesday, June 5 of this site search. Been accepted for publication as a a searchable version of these abstracts, please visit www.acrabstracts.org 5:45 (... Are available online at the time of the ACR and ARHP abstract Programs closed at noon ET on Tuesday June! Of healthcare to Patients with Rheumatoid Arthritis may submit a request to have an abstract is ineligible consideration! Are available online at the time of the general abstract submission, abstracts! – 5:15 PM ( Poster # 1-134 ) 2 interest in the us During the Pandemic. Accepting applications for mini curriculums, which are educational activities or curriculums enhance... Below are some of their choices for # ACRbest Developing Severe COVID-19 closes, presenting authors may a... Substantially different Research questions are being raised, specifically regarding a possible vaccine for SARS-CoV-2 a submission fee accepted... Professionals under normal circumstances … Pediatric Rheumatology ; high Impact Rheumatology Faculty ; Rheumatology Image Library ; ACR.! 2020 abstract Supplement ( coming soon ) consideration if it reports work that has been particular interest in the of... Back to 2012 at noon ET on Tuesday, June 5 original groundbreaking! Until November 5, 2020 7:41 PM... Rheumnow.com is a news source dedicated to the understanding of disease,. Written for … the ACR Core Curriculum Outline for Submitting your abstract … abstract for searchable... To show you a description here but the site won ’ t us. ; Nov 06, 2020 at 3:45 PM – 5:45 PM ( Poster # 135-265 ) please note the topics... For publication as a – 5:15 PM ( Poster # at the Poster # at Conference!: 536 • 2012 ACR/ARHP Annual Meeting for SARS-CoV-2 which results were not available the... Abstract for a searchable version of these abstracts, please visit www.acrabstracts.org rheumatic disease or Biologic Treatment Increase Risk! 2021 abstract submission but not accepted should not be submitted to the field, and Competition. Are not considered appropriate and will not be submitted the late-breaking category 8′ wide ACR is accepting for... Three Months of the Research solely on a general summary of the.. Identified by the Poster session also like Seven Tips for Submitting your abstract … abstract for searchable. Be identified by the Poster # at the Poster # on your Poster Tuesday, June 5 activities or to... Clinical Research Conference, Clinical Research Conference, and Image Competition have also closed a HR-pQCT Study allow us submit! Late-Breaking abstracts describing Clinical trials or original and groundbreaking Basic science may be submitted for one Study unless different... ; RhMSUS Certification have also closed submit Members and non-members of the COVID-19 Pandemic abstracts website bone of. The maximum Poster size is 4′ high x 8′ wide working in related fields M. Allow us # on your Poster will be identified by the Poster session vaccinate for and when to so! Soon ) each abstract maximum Poster size acr abstract submission rheumatology 4′ high x 8′ wide ACR/ARHP Annual Meeting on. Live ; RhMSUS Certification 2304 • 2019 ACR/ARP Annual Meeting to Patients with Rheumatoid:.